J. Goldman & Co’s Exact Sciences EXAS Stock Holding History

J. Goldman & Co’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,000	Closed	-$1.38M	–	490
2024 Q1	$1.38M	Buy	+20,000	New	+$1.27M	0.04%	245

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

J. Goldman & Co's EXAS Position: Q4 2015 in Review

J. Goldman & Co sold out of Exact Sciences (EXAS) in Q4 2015, closing a stake of 103,815 shares — an estimated $1.87M sold.

J. Goldman & Co first reported a position in EXAS in Q3 2015 and held it in 1 quarter. The position peaked at $1.87M in Q3 2015. 183 funds tracked by Wall St. Rank hold EXAS as of Q4 2015.

J. Goldman & Co reported no remaining Exact Sciences position as of Q4 2015 after selling out during the quarter.
J. Goldman & Co sold 103,815 Exact Sciences shares in Q4 2015, an estimated $1.87M.
J. Goldman & Co first reported a position in Exact Sciences in Q3 2015 and held it in 1 quarter.
J. Goldman & Co's Exact Sciences position peaked at $1.87M in Q3 2015.
183 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2015.

Based on J. Goldman & Co's 13F filing for Q4 2015, filed 10 Feb 2016.